Drive-line infections and sepsis in patients receiving the HVAD system as a left ventricular assist device

Ranjit John(University of Minnesota), Mark S. Slaughter(University of Louisville), David R. Hathaway(University of Chicago), Michael A. Acker(Hospital of the University of Pennsylvania), Walter E. Pae(Pennsylvania State University), Keith D. Aaronson(University of Michigan), Kevin B. Najarian(Heartware International (United States))
The Journal of Heart and Lung Transplantation
June 3, 2014
10.1016/j.healun.2014.05.010
Cited by 97

Related Papers

Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial
|The Lancet|2020|1k
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711
Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
|Circulation|2012|655